Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Freedman

Showing results (231-240 of 246) with videos related to

Pageof 25
Sort By:
Ophthalmology|December 18, 2024
Refractive Change at 5 Years in the Toddler Aphakia and Pseudophakia StudyDeborah K VanderVeen, M Edward Wilson, Jenny Y Wang, et al.
Ophthalmology|January 29, 2020
Outcomes of Bilateral Cataracts Removed in Infants 1 to 7 Months of Age Using the Toddler Aphakia and Pseudophakia Treatment Study RegistryErick D Bothun, M Edward Wilson, Deborah K Vanderveen, et al.
Ophthalmology|March 19, 2019
Outcomes of Unilateral Cataracts in Infants and Toddlers 7 to 24 Months of Age: Toddler Aphakia and Pseudophakia Study (TAPS)Erick D Bothun, M Edward Wilson, Elias I Traboulsi, et al.
Ophthalmology. Glaucoma|November 28, 2025
Glaucoma Management in Sturge-Weber Syndrome Using the Delphi ProcessKinza Abbas, Bailey Harrison, Ta Chen Peter Chang, et al.
American Journal of Ophthalmology|February 19, 2026
Stability of Astigmatism following Lensectomy for Pediatric CataractErick D Bothun, Desirae R Sutherland, Sarah R Hatt, et al.
The British Journal of Ophthalmology|August 14, 2021
Associations between systemic health and retinal nerve fibre layer thickness in preterm infants at 36 weeks postmenstrual ageLiangbo L Shen, Shwetha Mangalesh, Suzanne M Michalak, et al.
Ophthalmology|June 6, 2022
Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month OutcomesSharon F Freedman, Amra Hercinovic, David K Wallace, et al.
JAMA Ophthalmology|April 21, 2022
Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants, M Elizabeth Hartnett, David K Wallace, et al.
Ophthalmology|September 25, 2019
Assessment of Macular Microvasculature in Healthy Eyes of Infants and Children Using OCT AngiographyS Tammy Hsu, Hoan T Ngo, Sandra S Stinnett, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|January 21, 2023
Ocular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurityDavid K Wallace, Amra Hercinovic, Sharon F Freedman, et al.
Pageof 25

Showing results (231-240 of 246) with videos related to

Sort By:
Pageof 25
Ophthalmology|December 18, 2024
Refractive Change at 5 Years in the Toddler Aphakia and Pseudophakia StudyDeborah K VanderVeen, M Edward Wilson, Jenny Y Wang, et al.
Ophthalmology|January 29, 2020
Outcomes of Bilateral Cataracts Removed in Infants 1 to 7 Months of Age Using the Toddler Aphakia and Pseudophakia Treatment Study RegistryErick D Bothun, M Edward Wilson, Deborah K Vanderveen, et al.
Ophthalmology|March 19, 2019
Outcomes of Unilateral Cataracts in Infants and Toddlers 7 to 24 Months of Age: Toddler Aphakia and Pseudophakia Study (TAPS)Erick D Bothun, M Edward Wilson, Elias I Traboulsi, et al.
Ophthalmology. Glaucoma|November 28, 2025
Glaucoma Management in Sturge-Weber Syndrome Using the Delphi ProcessKinza Abbas, Bailey Harrison, Ta Chen Peter Chang, et al.
American Journal of Ophthalmology|February 19, 2026
Stability of Astigmatism following Lensectomy for Pediatric CataractErick D Bothun, Desirae R Sutherland, Sarah R Hatt, et al.
The British Journal of Ophthalmology|August 14, 2021
Associations between systemic health and retinal nerve fibre layer thickness in preterm infants at 36 weeks postmenstrual ageLiangbo L Shen, Shwetha Mangalesh, Suzanne M Michalak, et al.
Ophthalmology|June 6, 2022
Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month OutcomesSharon F Freedman, Amra Hercinovic, David K Wallace, et al.
JAMA Ophthalmology|April 21, 2022
Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants, M Elizabeth Hartnett, David K Wallace, et al.
Ophthalmology|September 25, 2019
Assessment of Macular Microvasculature in Healthy Eyes of Infants and Children Using OCT AngiographyS Tammy Hsu, Hoan T Ngo, Sandra S Stinnett, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|January 21, 2023
Ocular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurityDavid K Wallace, Amra Hercinovic, Sharon F Freedman, et al.
Pageof 25